Literature DB >> 1504513

Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome.

W J Driskell1, D L Ashley, J Grainger, S R Sirimanne, E P Mazzola, S W Page, L L Needham, R H Hill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504513     DOI: 10.1007/bf00195987

Source DB:  PubMed          Journal:  Bull Environ Contam Toxicol        ISSN: 0007-4861            Impact factor:   2.151


× No keyword cloud information.
  8 in total

1.  Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome.

Authors:  A N Mayeno; F Lin; C S Foote; D A Loegering; M M Ames; C W Hedberg; G J Gleich
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

2.  Update: analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-11-02       Impact factor: 17.586

3.  The cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

Authors:  K Sakimoto
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

4.  Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-08-31       Impact factor: 17.586

5.  Studies on models for tetrahydrofolic acid. 7. Reactions and mechanisms of tetrahydroquinoxaline derivatives at the formaldehyde level of oxidation.

Authors:  T H Barrows; P R Farina; L Chrzanowski; P A Benkovic; S J Benkovic
Journal:  J Am Chem Soc       Date:  1976-06-09       Impact factor: 15.419

6.  Eosinophilia-myalgia syndrome. Results of national surveillance.

Authors:  L A Swygert; E F Maes; L E Sewell; L Miller; H Falk; E M Kilbourne
Journal:  JAMA       Date:  1990-10-03       Impact factor: 56.272

7.  Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer.

Authors:  L Slutsker; F C Hoesly; L Miller; L P Williams; J C Watson; D W Fleming
Journal:  JAMA       Date:  1990-07-11       Impact factor: 56.272

8.  An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

Authors:  E A Belongia; C W Hedberg; G J Gleich; K E White; A N Mayeno; D A Loegering; S L Dunnette; P L Pirie; K L MacDonald; M T Osterholm
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

  8 in total
  3 in total

Review 1.  Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential.

Authors:  H Chen; J Rhodes
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

2.  A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).

Authors:  R M Silver; A Ludwicka; M Hampton; T Ohba; S A Bingel; T Smith; R A Harley; J Maize; M P Heyes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

3.  Distribution of L-tryptophan in normal and glucose - loaded mice.

Authors:  E L Sainio; S Närvänen; P Sainio; P Tuohimaa
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.